Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients
Pancreatectomy with vascular resection can be performed with low mortality in carefully selected patients. Unsuspected vascular involvement is relatively common (1 in 5). If autologous graft is not readily available, CryoVein is a safe alternative with similar perioperative outcomes.
Authors
- Carlos U. Corvera (ORCID: https://orcid.org/0000-0002-3092-8657)
- Kimberly S. Kirkwood (ORCID: https://orcid.org/0000-0002-6876-2752)
- Adnan Alseidi (ORCID: https://orcid.org/0000-0002-0365-1955)
- Ajay V. Maker (ORCID: https://orcid.org/0000-0002-8234-2762)
- Eric K. Nakakura (ORCID: https://orcid.org/0009-0007-3714-7072)
- Amir Ashraf‐Ganjouei (ORCID: https://orcid.org/0000-0003-2745-5032)
- Kenzo Hirose (ORCID: https://orcid.org/0000-0001-8167-2690)
- Mohamed A. Adam (ORCID: https://orcid.org/0000-0002-0059-7615)
- Phoebe Miller
- Alexa Glencer (ORCID: https://orcid.org/0000-0002-3183-1056)
- Ryutaro Hirose (ORCID: https://orcid.org/0000-0002-2307-0170)
- Kelli Ifuku
- Daniel B. Hoffman (ORCID: https://orcid.org/0000-0002-2302-6786)
- Fernanda Romero‐Hernández (ORCID: https://orcid.org/0000-0001-6014-9251)
Institutions
- University of California, San Francisco (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
Publication Details
- Journal
- Journal of Gastrointestinal Surgery
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.gassur.2024.08.016
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Institutes of Health